Firms urged to stockpile drugs to prevent Brexit shortages

The UK government has outlined how it will ensure the supply of medicines continues in the event of a “no deal” Brexit, urging companies to stockpile six weeks’ worth of medicine. With the March 2019 Brexit deadline looming ever closer, there are mounting concerns that the UK will be unable to reach an agreement over the country’s future relationship with the EU. Although the government is insisting this is unlikely, it has published a series of documents to help businesses plan for a no-deal scenario, including details about regulation of medicines. The document shows the government is willing to take a pragmatic approach in the event of a no-deal Brexit when the UK would cease to be a member of the EMA.